Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Satsuma Pharmaceuticals completes enrollment in Phase 3 Emerge trial » 16:11
06/01/20
06/01
16:11
06/01/20
16:11
STSA

Satsuma Pharmaceuticals

$25.00 /

-1.19 (-4.54%)

Satsuma Pharmaceuticals…

Satsuma Pharmaceuticals reported completion of enrollment and randomization in its EMERGE pivotal Phase 3 efficacy trial of STS101, dihydroergotamine nasal powder, for the acute treatment of migraine. Satsuma's President and Chief Executive Officer, John Kollins commented, "We are very pleased to have achieved this important milestone. We look forward to reporting EMERGE topline results in the second half of this year that we anticipate will further underscore the differentiating features of STS101, including robust anti-migraine activity and favorable tolerability that result from achieving DHE blood levels within what we believe is an optimal therapeutic window." "In addition, despite COVID-19 headwinds, our team has executed well, and we continue to advance development of STS101 per our plan and timelines. We remain on track to intiate enrollment in Q3 in the second STS101 Phase 3 trial, an open-label, multiple-administration safety trialin which patients will acutely treat their migraine attacks with STS101 on an ongoing and as-needed basis."

ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$25.00 /

-1.19 (-4.54%)

STSA Satsuma Pharmaceuticals
$25.00 /

-1.19 (-4.54%)

03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
STSA Satsuma Pharmaceuticals
$25.00 /

-1.19 (-4.54%)

Over a week ago
Conference/Events
Satsuma Pharmaceuticals to hold a pharmaceutical update conference call » 11:55
05/05/20
05/05
11:55
05/05/20
11:55
STSA

Satsuma Pharmaceuticals

$18.83 /

+ (+0.00%)

Chief Medical Officer,…

Chief Medical Officer, Detlef Albrecht, and Key Opinion Leader Dr. Ailani of MedStar Georgetown Headache Center discuss STS101 and the acute treatment of migraine on a conference call to be held on May 5 at 12 pm. Webcast Link

ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$18.83 /

+ (+0.00%)

03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
Conference/Events
Satsuma Pharmaceuticals to hold a pharmaceutical update conference call » 04:55
05/05/20
05/05
04:55
05/05/20
04:55
STSA

Satsuma Pharmaceuticals

$18.83 /

+0.83 (+4.61%)

Chief Medical Officer,…

Chief Medical Officer, Detlef Albrecht, and Key Opinion Leader Dr. Ailani of MedStar Georgetown Headache Center discuss STS101 and the acute treatment of migraine on a conference call to be held on May 5 at 12 pm. Webcast Link

ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$18.83 /

+0.83 (+4.61%)

03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
Over a month ago
Conference/Events
Satsuma Pharmaceuticals to hold a pharmaceutical update conference call » 08:07
04/29/20
04/29
08:07
04/29/20
08:07
STSA

Satsuma Pharmaceuticals

$19.12 /

-0.63 (-3.19%)

Chief Medical Officer,…

Chief Medical Officer, Detlef Albrecht, and Key Opinion Leader Dr. Ailani of MedStar Georgetown Headache Center discuss STS101 and the acute treatment of migraine on a conference call to be held on May 5 at 12 pm. Webcast Link

ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$19.12 /

-0.63 (-3.19%)

03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
Conference/Events
Satsuma Pharmaceuticals participates in a conference call with Mizuho » 04:55
04/13/20
04/13
04:55
04/13/20
04:55
STSA

Satsuma Pharmaceuticals

$17.88 /

+0.64 (+3.71%)

Conference call will be…

Conference call will be held on April 13 hosted by Mizuho.

ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$17.88 /

+0.64 (+3.71%)

03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
Conference/Events
Satsuma Pharmaceuticals participates in a conference call with Mizuho » 15:44
04/09/20
04/09
15:44
04/09/20
15:44
STSA

Satsuma Pharmaceuticals

$18.12 /

+0.88 (+5.10%)

Conference call will be…

Conference call will be held on April 13 hosted by Mizuho.

ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$18.12 /

+0.88 (+5.10%)

03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
Hot Stocks
Satsuma Pharmaceuticals Inc trading resumes  09:49
03/24/20
03/24
09:49
03/24/20
09:49
STSA

Satsuma Pharmaceuticals

$18.05 /

+ (+0.00%)

 
ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$18.05 /

+ (+0.00%)

03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
Hot Stocks
Satsuma Pharmaceuticals Inc trading halted, volatility trading pause  09:44
03/24/20
03/24
09:44
03/24/20
09:44
STSA

Satsuma Pharmaceuticals

$18.05 /

+ (+0.00%)

 
ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$18.05 /

+ (+0.00%)

03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
Hot Stocks
Satsuma Pharmaceuticals Inc trading halted, volatility trading pause  15:59
03/20/20
03/20
15:59
03/20/20
15:59
STSA

Satsuma Pharmaceuticals

$17.58 /

+3.36 (+23.63%)

 
ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$17.58 /

+3.36 (+23.63%)

03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
Hot Stocks
Satsuma Pharmaceuticals Inc trading resumes  11:57
03/13/20
03/13
11:57
03/13/20
11:57
STSA

Satsuma Pharmaceuticals

$19.03 /

+1.71 (+9.87%)

 
ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$19.03 /

+1.71 (+9.87%)

03/11/20 SVB Leerink
Satsuma Pharmaceuticals price target raised to $35 from $20 at SVB Leerink
03/02/20 Credit Suisse
Satsuma Pharmaceuticals price target raised to $32 from $20 at Credit Suisse
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho
02/05/20 Mizuho
Satsuma Pharmaceuticals initiated with a Buy at Mizuho

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.